Tiotropium bromide: role in the treatment of chronic obstructive pulmonary disease

Tiotropium bromide: role in the treatment of chronic obstructive pulmonary disease

Bibliographic Details
Main Author:	A I Sinopalnikov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2004-03-01
Series:	Терапевтический архив
Subjects:	chronic obstructive pulmonary diseases treatment tiotropium bromide
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/29759

Similar Items

Legal demands of the tiotropium bromide for treatment of chronic obstructive pulmonary disease and their financial impact for the State of Paraná, Brazil
by: Renata Szpak, et al.

The influence of basic treatment with tiotropium bromide of patients with chronic obstructive pulmonary disease stage II on the morpho-functional state of bronchial mucosa and the level of type IV collagen in bronchoalveolar lavage fluid.
by: Mykola Osyrovskyy, et al.
Published: (2018-12-01)

Efficiency of tiotropium bromide in patients with severe persistent bronchial asthma in clinical practice
by: A. F. Ivanov, et al.
Published: (2018-04-01)

Thiotropium bromide in the treatment of chronic obstructive pulmonary disease
by: E I Shmelev
Published: (2003-12-01)

Tiotropium bromide exerts anti-inflammatory effects during resistive breathing, an experimental model of severe airway obstruction
by: Toumpanakis D, et al.
Published: (2017-07-01)

PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. U. Kulikov, et al.
Published: (2015-03-01)

Expression of Muscarinic Receptors and the Effect of Tiotropium Bromide in Aged Mouse Model of Chronic Asthma
by: Ji Young Kang, M.D., Ph.D., et al.
Published: (2019-01-01)

Determination of clinical phenotypes of chronic obstructive pulmonary disease a new treatment approach
by: Sergey Nikolaevich Avdeev, et al.
Published: (2011-03-01)

Bronchodilator treatment of stable COPD: long-acting anticholinergics
by: W. Vincken
Published: (2005-09-01)

Pharmacoeconomic analysis of the use of a fixed combination of tiotropium bromide and olodaterol as maintenance therapy in patients with chronic obstructive pulmonary disease in the Russian Federation
by: S. К. Zyryanov, et al.
Published: (2022-07-01)

Tiotropium bromide as adjunct therapy in children with asthma: a clinical experience
by: Zainab Ridha, et al.
Published: (2021-12-01)

Pharmacoeconomic aspects of the use of bronchodilators in the management of COPD: real clinical practice
by: Р. A. Balunov, et al.
Published: (2019-01-01)

Changes in functional status and inflammation profile in patients with chronic obstructive pulmonary disease during therapy with tiotropium
by: I. N. Trofimenko, et al.
Published: (2015-12-01)

Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China
by: Lan Y, et al.
Published: (2023-09-01)

BRONCHOPROTECTIVE EFFECT OF GLYCOPYRRONIUM BROMIDE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: I. N. Trofimenko, et al.
Published: (2017-11-01)

The efficacy of thiotropium bromide (Spiriva) in the treatment of patients with chronic obstructive pulmonary disease of varying severity: results of the Russian trial
by: Igor' Emil'evich Stepanyan, et al.
Published: (2010-10-01)

Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis
by: David M. G. Halpin, et al.
Published: (2020-03-01)

Tiotropium as essential maintenance therapy in COPD
by: M. Decramer
Published: (2006-12-01)

Is it possible to modify the course of chronic obstructive pulmonary disease with modern medication?
by: S N Avdeev
Published: (2008-08-01)

Double-blind Randomized Parallel Group Study Comparing the Efficacy and Safety of Tiotropium and Ipratropium in the Treatment of COPD Patients in Taiwan
by: Jeng-Yuan Hsu, et al.
Published: (2006-01-01)

Current optimization of combined therapy for chronic obstructive pulmonary disease
by: E N Popova
Published: (2015-12-01)

Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD
by: Andreas S, et al.
Published: (2020-08-01)

COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD
by: E. G. Kosolapov, et al.
Published: (2017-08-01)

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study
by: Sauer R, et al.
Published: (2016-04-01)

Assessment of physical functioning and handling of tiotropium/olodaterol Respimat® in patients with COPD in a real-world clinical setting
by: Steinmetz KO, et al.
Published: (2019-07-01)

A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS)
by: Naeemeh Dini, et al.
Published: (2024-04-01)

The evolving role of tiotropium in asthma
by: McIvor ER, et al.
Published: (2017-08-01)

Role of Tiotropium as Step Up Therapy for Asthma
by: Muhammad Usman Ullah
Published: (2013-12-01)

Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients
by: Valipour A, et al.
Published: (2019-10-01)

Clinical effectiveness of anticholinergic tiotropium bromide as an add-on therapy in patients with severe bronchial asthma: A randomized controlled trial
by: V G Santhosh, et al.
Published: (2017-01-01)

Comparison of Tetropium and β2 Agonist Therapy in Patients with Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis
by: Hamidreza Dehghan, et al.
Published: (2017-09-01)

Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium
by: Beeh Kai-Michael, et al.
Published: (2012-06-01)

Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study
by: Hsieh MJ, et al.
Published: (2022-04-01)

Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
by: Nalini Jayanthi, et al.
Published: (2022-08-01)

Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation
by: S. V. Nedogoda, et al.
Published: (2020-08-01)

ANTIBACTERIAL THERAPY OF EXACERBATIONS OF CHRONIC BRONCHITIS/CHRONIC OBSTRUCTIVE PULMONARY DISEASE: KEY PROVISIONS
by: A. I. Sinopalnikov, et al.
Published: (2017-11-01)

COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD
by: E. G. Kosolapov, et al.
Published: (2017-08-01)

Superiority of tiotropium plus olodaterol in comparison with salmeterol plus fluticasone
by: Tamura T, et al.
Published: (2016-11-01)

Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History
by: Sethi S, et al.
Published: (2023-04-01)

Chronic obstructive pulmonary disease: Strategic aspects of treatment
by: Evgeniy Ivanovich Shmelev, et al.
Published: (2011-08-01)